Acetylation is pivotal in p53 activation, and the suppression of fatty acid binding protein 4 (FABP4) activates SIRT1, which in turn deacetylates p53-STAT, thereby inhibiting pyroptosis and mitigating type 2 diabetes [28]. This evidence concerns the gene FABP4 and type 2 diabetes mellitus.